Browsing by Author "Mardekian, Jack"
Now showing items 1-3 of 3
-
Economic outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate plus prednisone
Ramaswamy, Krishnan; Lechpammer, Stanislav; Mardekian, Jack; Huang, Ahong; Schultz, Neil M.; Sandin, Rickard; Wang, Li; Başer, Onur; George, Daniel J. (Springer, 2020)Introduction: Prostate cancer (PC) is the second leading cause of cancer death among US men and accounts for considerable healthcare expenditures. We evaluated economic outcomes in men with chemotherapy-naı¨ve metastatic ... -
Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States medicare population
Amin, Alpesh; Keshishian, A; Trocio, Jeffrey; Dina, Oluwaseyi; Le, Hannah; Rosenblatt, Lisa; Liu, Xianchen; Mardekian, Jack; Zhang, Qisu; Başer, Onur; Lien Vo (2017)Objective: To compare the risk and cost of stroke/systemic embolism (SE) and major bleeding between each direct oral anticoagulant (DOAC) and warfarin among non-valvular atrial fibrillation (NVAF) patients. Methods: Patients ... -
Warfarin discontinuation in patientswith unprovoked venous thromboembolism: a large us insurance database analysis
Xie, Lin; Liu, Xianchen; Phatak, Hemant; Mardekian, Jack; Tan, Wilson; Başer, Onur; Ramacciotti, Eduardo (2016)This study examined warfarin therapy discontinuation and its risk factors among patients with unprovoked venous thromboembolism (VTE) in the US clinical practice setting. Adult patients with unprovoked VTE were identified ...
